84
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Efficacy, tolerance and acceptability of pulsed dye laser on facial and neckline telangiectasias in systemic scleroderma: a prospective open-label monocentric study in 21 patients

ORCID Icon, , , , , , & show all
Pages 77-85 | Received 19 Jun 2022, Accepted 29 Jan 2024, Published online: 19 Feb 2024

References

  • Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009 May 7;360(19):1989–2003. doi:10.1056/NEJMra0806188.
  • Johnson SR. New ACR EULAR guidelines for systemic sclerosis classification. Curr Rheumatol Rep. 2015 May;17(5):32. doi:10.1007/s11926-015-0506-3.
  • Braverman IM, Ken-Yen A. Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol. 1983 Dec;81(6):489–97. doi:10.1111/1523-1747.ep12522736.
  • Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002 Mar;81(2):139–53. doi:10.1097/00005792-200203000-00004
  • Ashida R, Ihn H, Mimura Y, Jinnin M, Asano Y, Kubo M, Tamaki, K. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia. Clin Exp Dermatol. 2009 Oct;34(7):781–3. doi:10.1111/j.1365-2230.2008.03148.x
  • Zhang SZ, Xu D, Tao LM, Hou Y, Wang Q, Tian Z, Liu YT, Guo XX, Lai JZ, Zhao JL, et al. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China. Clin Exp Rheumatol. 2015 Aug;33(4 Suppl 91):S106–110.
  • Jouvray M, Launay D, Dubucquoi S, Sobanski V, Podevin C, Lambert M, Morell-Dubois S, Maillard H, Hatron P-Y, Hachulla E, et al. Whole-body distribution and clinical association of telangiectases in systemic sclerosis. JAMA Dermatology. 2018 Jul 1;154(7):796–805. doi:10.1001/jamadermatol.2018.0916
  • Peres N, Morell-Dubois S, Hachulla E, Hatron PY, Duhamel A, Godard D, Tellart-Mamert AS, Lambert M, Launay D, Fantoni-Quinton S. [Systemic sclerosis and occupational difficulties: results of a prospective study]. Rev Med Interne. 2017 Nov;38(11):718–24. doi:10.1016/j.revmed.2017.06.006
  • Kwon WJ, Park BW, Cho EB, Park EJ, Kim KH, Kim KJ. Comparison of efficacy between long-pulsed Nd: YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia. J Cosmet Laser Ther. 2018 Jul 4;20(5):260–64. doi:10.1080/14764172.2017.1418510.
  • Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci. 2019 Feb;34(1):93–98. doi:10.1007/s10103-018-2606-6.
  • Gao L, Qu H, Gao N, Li K, Dang E, Tan W, Wang G. A retrospective analysis for facial telangiectasia treatment using pulsed dye laser and intense pulsed light configured with different wavelength bands. J Cosmet Dermatol. 2020 Jan;19(1):88–92. doi:10.1111/jocd.13179
  • Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010 Feb;24(2):143–46. doi:10.1111/j.1468-3083.2009.03357.x.
  • Dinsdale G, Murray A, Moore T, Ferguson J, Wilkinson J, Richards H, Griffiths CE, Herrick AL. A comparison of intense pulsed light and laser treatment of telangiectases in patients with systemic sclerosis: a within-subject randomized trial. Rheumatology (Oxford). 2014 Aug;53(8):1422–30. doi:10.1093/rheumatology/keu006
  • Ciatti S, Varga J, Greenbaum SS. The 585 nm flashlamp-pumped pulsed dye laser for the treatment of telangiectases in patients with scleroderma. J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):487–8. doi:10.1016/S0190-9622(96)90638-6.
  • Halachmi S, Gabari O, Cohen S, Koren R, Amitai DB, Lapidoth M. Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment. Lasers Med Sci. 2014 Jan;29(1):137–40. doi:10.1007/s10103-013-1298-1.
  • Burillo-Martinez S, Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, López-Gómez S, Maroñas-Jimenez L. Case series of pulsed dye laser treatment of telangiectasia in 23 patients with systemic sclerosis. Int J Dermatol. 2017;56(8):e165–7. doi:10.1111/ijd.13595.
  • Ndounga Diakou LA, Trinquart L, Hróbjartsson A, Barnes C, Yavchitz A, Ravaud P, Boutron I. Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates. Cochrane Methodol Revi Group, Editor. Cochrane Database Of System Revie. 20163: Internet2021 Mar 10[cited 2016 Jul 5]; Available from https://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000043.pub2.
  • Dechartres A, Boutron I, Roy C, Ravaud P. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal. J Clin Epidemiol. 2009 Jul;62(7):695–702. doi:10.1016/j.jclinepi.2008.09.011.
  • Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey‐Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. Sep;71(9):1400–12. doi:10.1002/art.40930
  • Liu A, Moy RL, Ross EV, Hamzavi I, Ozog DM. Pulsed dye laser and pulsed dye laser-mediated photodynamic therapy in the treatment of dermatologic disorders. Dermatol Surg. 2012 Mar;38(3):351–66. doi:10.1111/j.1524-4725.2011.02293.x.
  • Greve B, Raulin C. Prospective study of port wine stain treatment with dye laser: comparison of two wavelengths (585 nm vs. 595 nm) and two pulse durations (0.5 milliseconds vs. 20 milliseconds). Lasers Surg Med. 2004;34(2):168–73. doi:10.1002/lsm.20003.
  • Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, et al. The European scleroderma trials and research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017 Jan;76(1):270–76. doi:10.1136/annrheumdis-2016-209768
  • Gupta V, Sharma VK. Skin typing: Fitzpatrick grading and others. Clin Dermatol. 2019 Oct;37(5):430–36. doi:10.1016/j.clindermatol.2019.07.010.
  • Martins JMP, FDS de O, Lima EOC, Dullius D, de O DI, Hiraiwa E, Serrano T, Teixeira GR, Sampaio PM, Collares MV. Use of derived adipose stem cells to reduce complications of cutaneous scarring in smokers. An experimental model in rats. Acta Cir Bras. 2019 Aug 19;34(6):e201900605. doi:10.1590/s0102-865020190060000005
  • Hexsel D, Hexsel CL, Dal’forno T, Schilling de Souza J, Silva AF, Siega C. Standardized methods for photography in procedural dermatology using simple equipment. Int J Dermatol. 2017 Apr;56(4):444–51. doi:10.1111/ijd.13500.
  • Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996 Nov;107(5):707–13. doi:10.1111/1523-1747.ep12365600.
  • Leplège A, Ecosse E, Zeller J, Revuz J, Wolkenstein P. The French version of skindex (skindex-france). Adaptation and assessment of psychometric properties. Ann Dermatol Venereol. 2003 Feb;130(2 Pt 1):177–83.
  • Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr (Engl Ed). 2021 Jan;112(1):90–2. doi:10.1016/j.ad.2019.05.009.
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016 Jun;15(2):155–63. doi:10.1016/j.jcm.2016.02.012.
  • Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012 Feb;44(2):97–102. doi:10.1002/lsm.21151.
  • Hurabielle C, Avouac J, Lepri G, de Risi T, Kahan A, Allanore Y. Skin telangiectasia and the identification of a subset of systemic sclerosis patients with severe vascular disease: SSc patients and skin telangiectasia. Arthritis Care Res (Hoboken). 2016 Jul;68(7):1021–27. doi:10.1002/acr.22766.
  • Meijs MM, Blok FAA, de Rie MA. Treatment of poikiloderma of civatte with the pulsed dye laser: a series of patients with severe depigmentation. J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1248–51. doi:10.1111/j.1468-3083.2006.01782.x.
  • Chang YC, Lee SJ, Chung HJ. Treatment of post-pulsed dye laser purpura with pulsed dye laser. J Cosmet Laser Ther. 2018 Jan 2;20(1):21–23. doi:10.1080/14764172.2017.1368563.
  • Mayo TT, Khan F, Hunt C, Fleming K, Markus R. Comparative study on bruise reduction treatments after bruise induction using the pulsed dye laser. Dermatol Surg. 2013 Oct;39(10):1459–64. doi:10.1111/dsu.12293.
  • Karen JK, Hale EK, Geronemus RG. A simple solution to the common problem of ecchymosis. Arch Dermatol. 2010 Jan;146(1):94–95. doi:10.1001/archdermatol.2009.343.
  • DeFatta RJ, Krishna S, Williams EF. Pulsed-dye laser for treating ecchymoses after facial cosmetic procedures. Arch Facial Plast Surg. 2009 Apr;11(2):99–103. doi:10.1001/archfaci.2008.538.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.